1.3K
Publications
116.4K
Citations
68
Authors
Osaka
Japan
Other names
アストラゼネカ株式会社
AstraZeneca (Japan) is a company institution in Osaka, Japan known for medicine, oncology, and radiation oncology.
1.3K
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo et al. · NEJM Evidence · 2022 · 1.3K citations · Full text
Rows per page
1–5 of 1.3K
68
| Publications | Citations | H-Index | |
|---|---|---|---|
TY AstraZeneca (Japan) | 101 | 2.6K | 27 |
YI AstraZeneca (Japan) | 188 | 4.6K | 25 |
MA AstraZeneca (Japan) | 77 | 1.1K | 18 |
MN AstraZeneca (Japan) | 41 | 845 | 16 |
NH AstraZeneca (Japan) | 41 | 750 | 15 |
Rows per page
1–5 of 68